Your Location:
Home >
Browse articles >
Excellent effects and possible mechanisms of action of a new antibody–drug conjugate against EGFR-positive triple-negative breast cancer
RESEARCH | Updated:2023-02-28
    • Excellent effects and possible mechanisms of action of a new antibody–drug conjugate against EGFR-positive triple-negative breast cancer

    • Dan-Dan Zhou , Wei-Qi Bai , Xiao-Tian Zhai , Li-Ping Sun , Yong-Su Zhen , Zhuo-Rong Li , Qing-Fang Miao
    • Military Medical Research Vol. 9, Issue 4, Pages: 419-431(2022)
    • DOI: 10.1186/s40779-021-00358-9     

      CLC:

    Scan QR Code

  •  
  •  
  • Full Text(HTML)

  • Figs( 7 ) Tabs( 0 )

  • References

  • Publication Info

  • Metrics

Sections
icon
The trial reading is over, you can activate your VIP account to continue reading.
Deactivate >
icon
The trial reading is over. You can log in to your account, go to the personal center, purchase VIP membership, and read the full text.
Already a VIP member?
Log in >

14

Views

22

Downloads

1

CSCD

Alert me when the article has been cited
Submit
Tools
  • BibTeXDownload
  • EndnoteDownload
  • RefMan Download
  • NoteExpressDownload
  • NoteFirstDownload

Related Articles

Crosstalk in the brain tumor microenvironment: mechanisms, therapeutic strategies, and clinical advances
Reprogramming neural-tumor crosstalk: emerging therapeutic dimensions and targeting strategies
The efficacy of tucatinib-based therapeutic approaches for HER2-positive breast cancer
Expression of epidermal growth factor and its receptor in gestational trophoblastic diseases
Engineering of functional auditory neurons from human induced pluripotent stem cells

Related Author

Liu Chen
Rong-Rong Zhou
Paul R Lockman
Thomas Michael Marti
Hai-Bin Deng
Mu-Yuan Jia
Jie Yang
Ke-Qin Zhang

Related Institution

Department of Radiation Oncology, Hunan Cancer Hospital/Affiliated Hospital of Xiangya School of Medicine, Central South University
Xiangya Lung Cancer Center, Xiangya Hospital, Central South University
Department of Neuroscience, West Virginia University School of Medicine, Rockefeller Neuroscience Institute
Department of Pharmaceutical Sciences, West Virginia University School of Pharmacy
Department for BioMedical Research, University of Bern